ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 118 filers reported holding ACCELERATE DIAGNOSTICS INC in Q1 2018. The put-call ratio across all filers is 2.95 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $10 | +25.0% | 11,940 | +11.2% | 0.00% | 0.0% |
| Q1 2023 | $8 | 0.0% | 10,740 | 0.0% | 0.00% | -80.0% |
| Q4 2022 | $8 | -100.0% | 10,740 | 0.0% | 0.01% | -44.4% |
| Q3 2021 | $63,000 | -33.7% | 10,740 | -8.5% | 0.01% | -35.7% |
| Q2 2021 | $95,000 | -5.9% | 11,740 | -3.3% | 0.01% | -22.2% |
| Q1 2021 | $101,000 | +9.8% | 12,140 | 0.0% | 0.02% | -10.0% |
| Q4 2020 | $92,000 | -28.7% | 12,140 | 0.0% | 0.02% | -52.4% |
| Q3 2020 | $129,000 | -49.2% | 12,140 | -27.5% | 0.04% | -56.2% |
| Q2 2020 | $254,000 | +76.4% | 16,740 | -4.6% | 0.10% | +26.3% |
| Q1 2020 | $144,000 | -37.1% | 17,540 | +29.5% | 0.08% | -18.3% |
| Q4 2019 | $229,000 | -8.8% | 13,540 | 0.0% | 0.09% | -40.8% |
| Q3 2019 | $251,000 | -12.5% | 13,540 | +8.0% | 0.16% | -14.7% |
| Q2 2019 | $287,000 | +8.7% | 12,540 | 0.0% | 0.18% | -8.5% |
| Q1 2019 | $264,000 | +83.3% | 12,540 | 0.0% | 0.20% | +44.6% |
| Q4 2018 | $144,000 | -50.0% | 12,540 | 0.0% | 0.14% | -35.0% |
| Q3 2018 | $288,000 | +17.1% | 12,540 | +13.6% | 0.21% | +0.9% |
| Q2 2018 | $246,000 | -8.6% | 11,040 | -6.4% | 0.21% | -17.5% |
| Q1 2018 | $269,000 | -12.9% | 11,790 | 0.0% | 0.26% | -20.2% |
| Q4 2017 | $309,000 | +16.6% | 11,790 | 0.0% | 0.32% | -2.4% |
| Q3 2017 | $265,000 | -17.7% | 11,790 | 0.0% | 0.33% | +226.7% |
| Q2 2017 | $322,000 | – | 11,790 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 225,239 | $1,295,123 | 1.10% |
| CHARTIST INC /CA/ | 67,073 | $385,667 | 0.23% |